Frontlight ResearchEarly access
Active, not recruitingNo phase
Post-Approval Study of the TREO Abdominal Stent-Graft System
Key facts
- Who runs it
- Bolton Medical
- Where
- Asheville, Atlanta, Aurora, Austin, Bay City, Boston, Detroit, Fresno, Gainesville, Greenville, Hackensack, Iowa City, Kingsport, La Jolla, Milwaukee, Minneapolis, New Brunswick, New Haven, New York, Norfolk, Oklahoma City, Pensacola, Philadelphia, Phoenix, Pittsburgh, Portland, Richmond, Salt Lake City, San Diego, St Louis, Stony Brook, Syracuse, Tampa, The Bronx, Tucson, and Washington D.C., United StatesSee the 40 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 338 people enrolled
- Started
- 20 Jan 2021
- Expected to end
- 31 Oct 2028
- Type of study
- Interventional
- Treatments tested
- TREO Abdominal Stent-Graft System
- Record updated
- 13 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Willing and able to comply with all study procedures and visits
- Written informed consent to participate in the study
- Patient's aneurysm can be treated with the TREO Abdominal Stent-Graft System
- Adequate data (medical records/imaging studies) available to analyze the primary endpoints for patients enrolled retrospectively
Who cannot take part
- Medical, social or psychological problems that, in the opinion of the investigator, preclude patient from receiving treatment with the TREO Abdominal Stent-Graft System
Where in United States
- Mission HealthAsheville, United States
- Northside HospitalAtlanta, United States
- Piedmont Heart InstituteAtlanta, United States
- University of Colorado AnschutzAurora, United States
- St. David's Healthcare (Cardiothoracic and Vascular Surgeons)Austin, United States
- McLaren-Bay RegionBay City, United States
- Massachusetts General HospitalBoston, United States
- Tufts Medical CenterBoston, United States
- Henry Ford HospitalDetroit, United States
- University of California San Francisco-FresnoFresno, United States
- Malcom Randall VA Medical CenterGainesville, United States
- University of FloridaGainesville, United States
- East Carolina UniversityGreenville, United States
- Hackensack University Medical CenterHackensack, United States
- University of Iowa Hospital and ClinicIowa City, United States
- Wellmont Cardiology ServicesKingsport, United States
- University of California San DiegoLa Jolla, United States
- Medical College of WisconsinMilwaukee, United States
- Minneapolis Heart Institute FoundationMinneapolis, United States
- Rutgers Robert Wood Johnson Medical CenterNew Brunswick, United States
- Yale UniversityNew Haven, United States
- Lenox Hill Hospital | Northwell HealthNew York, United States
- Sentara Heart HospitalNorfolk, United States
- University of Oklahoma Health Sciences CenterOklahoma City, United States
- Coastal Vascular and InterventionalPensacola, United States
- Temple University HospitalPhiladelphia, United States
- Vascular Surgery SpecialistsPhoenix, United States
- University of Pittsburgh Medical CenterPittsburgh, United States
- Oregon Health and Science UniversityPortland, United States
- VA Portland Healthcare SystemPortland, United States
- Virginia Commonwealth UniversityRichmond, United States
- University of Utah HospitalSalt Lake City, United States
- VA San DiegoSan Diego, United States
- Barnes Jewish Hospital at Washington UniversitySt Louis, United States
- Stony Brook Medical CenterStony Brook, United States
- SUNY Upstate Medical UniversitySyracuse, United States
- University of South Florida (Tampa General Hospital)Tampa, United States
- Montefiore Medical CenterThe Bronx, United States
- PIMA Heart and VascularTucson, United States
- MedStar Washington Hospital CenterWashington D.C., United States
About the trial
What the trial wants to find out
The purpose of this study is to determine the long-term performance of the TREO Abdominal Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms.
The group in the trial
- Subjects who receive the TREO Abdominal Stent-Graft SystemTreatment being tested
Eligible subjects will be implanted with the TREO Abdominal Stent-Graft System.
Treatment: TREO Abdominal Stent-Graft System
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Post-Approval Study of the TREO Abdominal Stent-Graft System (P190015) in Patients With Infrarenal Abdominal Aortic and Aorto-iliac Aneurysms
- Record updated
- 13 November 2026